OBJECTIVE: UTUCC is a rare tumor, and most reports on prognostic factors come from small single-center series. The objective of this article was to provide an updated overview of current clinical, pathological and biological prognostic factors of UTUC. METHODS: PubMed was searched for records from 2002 to 2010 using the terms "prognostic factors", "recurrence", "survival", and "upper tract urothelial carcinoma". Among identified citations, papers were selected based on their clinical relevance. RESULTS: Classical clinical factors that influence UTUC prognosis include age, presence of symptoms, hydronephrosis, and interval from diagnosis. Many biomarkers have shown promises to better appraise the natural course of UTUC although none is currently used in clinical practice. Stage, grade, lymph node metastases, lymphovascular invasion, tumor necrosis, and tumor architecture are strong pathological parameters. RNU is the standard treatment of localized UTUC. Both laparoscopic and open approaches seem to offer similar cancer control. Lymph node dissection increases staging accuracy and might confer a survival benefit. CONCLUSION: RNU is the standard treatment for most patients with UTUC. Recent multicenter studies confirmed the prognostic value of classical prognostic parameters. Better survival prediction might be obtained with prognostic systems including clinical data and new biomarkers.
OBJECTIVE: UTUCC is a rare tumor, and most reports on prognostic factors come from small single-center series. The objective of this article was to provide an updated overview of current clinical, pathological and biological prognostic factors of UTUC. METHODS: PubMed was searched for records from 2002 to 2010 using the terms "prognostic factors", "recurrence", "survival", and "upper tract urothelial carcinoma". Among identified citations, papers were selected based on their clinical relevance. RESULTS: Classical clinical factors that influence UTUC prognosis include age, presence of symptoms, hydronephrosis, and interval from diagnosis. Many biomarkers have shown promises to better appraise the natural course of UTUC although none is currently used in clinical practice. Stage, grade, lymph node metastases, lymphovascular invasion, tumor necrosis, and tumor architecture are strong pathological parameters. RNU is the standard treatment of localized UTUC. Both laparoscopic and open approaches seem to offer similar cancer control. Lymph node dissection increases staging accuracy and might confer a survival benefit. CONCLUSION: RNU is the standard treatment for most patients with UTUC. Recent multicenter studies confirmed the prognostic value of classical prognostic parameters. Better survival prediction might be obtained with prognostic systems including clinical data and new biomarkers.
Authors: Giovanni Lughezzani; Maxine Sun; Paul Perrotte; Shahrokh F Shariat; Claudio Jeldres; Lars Budäus; Mathieu Latour; Hugues Widmer; Alain Duclos; Francois Bénard; Michael McCormack; Francesco Montorsi; Pierre I Karakiewicz Journal: Urology Date: 2009-12-04 Impact factor: 2.649
Authors: Marco Roscigno; Shahrokh F Shariat; Massimo Freschi; Vitaly Margulis; Pierre Karakiewizc; Nazareno Suardi; Mesut Remzi; Richard Zigeuner; Christian Bolenz; Eiji Kikuchi; Alon Weizer; Karim Bensalah; Arthur Sagalowsky; Theresa M Koppie; Jay Raman; Mario Fernández; Philipp Ströbel; Wareef Kabbani; Cord Langner; Jeffery Wheat; Charles C Guo; Wassim Kassouf; Andrea Haitel; Christopher G Wood; Francesco Montorsi Journal: Urology Date: 2009-11 Impact factor: 2.649
Authors: Hendrik Isbarn; Claudio Jeldres; Shahrokh F Shariat; Daniel Liberman; Maxine Sun; Giovanni Lughezzani; Hugues Widmer; Philippe Arjane; Daniel Pharand; Margit Fisch; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz Journal: J Urol Date: 2009-09-16 Impact factor: 7.450
Authors: Umberto Capitanio; Shahrokh F Shariat; Hendrik Isbarn; Alon Weizer; Mesut Remzi; Marco Roscigno; Eiji Kikuchi; Jay D Raman; Christian Bolenz; Karim Bensalah; Theresa M Koppie; Wassim Kassouf; Mario I Fernández; Philipp Ströbel; Jeffrey Wheat; Richard Zigeuner; Cord Langner; Matthias Waldert; Mototsugu Oya; Charles C Guo; Casey Ng; Francesco Montorsi; Christopher G Wood; Vitaly Margulis; Pierre I Karakiewicz Journal: Eur Urol Date: 2009-04-03 Impact factor: 20.096
Authors: Marco Roscigno; Shahrokh F Shariat; Vitaly Margulis; Pierre Karakiewicz; Mesut Remzi; Eiji Kikuchi; Richard Zigeuner; Alon Weizer; Arthur Sagalowsky; Karim Bensalah; Jay D Raman; Christian Bolenz; Wassim Kassou; Theresa M Koppie; Christopher G Wood; Jeffrey Wheat; Cord Langner; Casey K Ng; Umberto Capitanio; Roberto Bertini; Mario I Fernández; Shuji Mikami; Masaru Isida; Philipp Ströbel; Francesco Montorsi Journal: Eur Urol Date: 2009-06-18 Impact factor: 20.096
Authors: M Rink; M Adam; J Hansen; F K Chun; S A Ahyai; M Remzi; T Schlomm; O Engel; R Heuer; C Eichelberg; M Fisch; R Dahlem; S F Shariat Journal: Urologe A Date: 2012-09 Impact factor: 0.639
Authors: Harun Fajkovic; Eugene K Cha; Evanguelos Xylinas; Michael Rink; Armin Pycha; Christian Seitz; Christian Bolenz; Allison Dunning; Giacomo Novara; Quoc-Dien Trinh; Pierre I Karakiewicz; Vitaly Margulis; Jay D Raman; Thomas J Walton; Shiro Baba; Joaquin Carballido; Wolfgang Otto; Francesco Montorsi; Yair Lotan; Wassim Kassouf; Hans-Martin Fritsche; Karim Bensalah; Richard Zigeuner; Douglas S Scherr; Guru Sonpavde; Morgan Roupret; Shahrokh F Shariat Journal: World J Urol Date: 2012-09-26 Impact factor: 4.226
Authors: G Bozzini; L Nison; P Colin; A Ouzzane; D R Yates; F Audenet; G Pignot; A Arvin-Berod; O Merigot; L Guy; J Irani; F Saint; S Gardic; P Gres; F Rozet; Y Neuzillet; A Ruffion; M Roupret Journal: World J Urol Date: 2012-10-11 Impact factor: 4.226
Authors: Sang Hun Song; Chang Hee Ye; Sangchul Lee; Sung Kyu Hong; Seok-Soo Byun; Sang Eun Lee; Jong Jin Oh Journal: J Cancer Res Clin Oncol Date: 2019-09-09 Impact factor: 4.553
Authors: Stephanie Kriebel; Doris Schmidt; Stefan Holdenrieder; Diane Goltz; Glen Kristiansen; Rudolf Moritz; Christian Fisang; Stefan C Müller; Jörg Ellinger Journal: PLoS One Date: 2015-01-28 Impact factor: 3.240